Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 262

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 262
---
 Statement/Prospectus in comparison to any document incorporated by reference into this Proxy Statement/Prospectus, or among documents incorporated by reference, the information in the latest filed document controls. You should rely only on the information contained or incorporated by reference into this Proxy Statement/Prospectus. No one has been authorized to provide you with information that is different from that contained in, or incorporated by reference into, this Proxy Statement/Prospectus. This Proxy Statement/Prospectus is dated March 20, 2025. You should not assume that the information contained in this Proxy Statement/Prospectus is accurate as of any date other than that date. You should not assume that the information incorporated by reference into this Proxy Statement/Prospectus is accurate as of any date other than the date of such incorporated document. Neither Enfusion’s mailing of this Proxy Statement/Prospectus to Enfusion Stockholders nor the issuance by Clearwater of Clearwater Common Stock in the Merger will create any implication to the contrary. This document contains a description of the representations and warranties that each of Clearwater, Acquirer, Merger Sub, Merger Sub II and Enfusion made in the Merger Agreement. Representations and warranties made by Clearwater, Enfusion and other applicable parties are also set forth in contracts and other documents that are attached or filed as exhibits to this Proxy Statement/Prospectus or are incorporated by reference into this Proxy Statement/Prospectus. These materials are included or incorporated by reference to provide you with information regarding the terms and conditions of the agreements. Accordingly, the representations and warranties and other provisions of the Merger Agreement should not be read alone, but instead should be read only in conjunction with the other information provided elsewhere in this Proxy Statement/Prospectus or incorporated by reference into this Proxy Statement/Prospectus. 188

ANNEX A

EXECUTION COPY

AGREEMENT AND PLAN OF MERGER

by and among

ENFUSION, INC.,

ENFUSION LTD. LLC,

CLEARWATER ANALYTICS HOLDINGS, INC.

POSEIDON ACQUIRER, INC.

POSEIDON MERGER SUB I, INC.

and

POSEIDON MERGER SUB II, LLC

JANUARY 10, 2025

TABLE OF CONTENTS

|                                                          |     |                                                                  |     | Page |      |
| ARTICLE I DEFINITIONS                                    |     |                                                                  |     |      | A-2  |
| Section 1